Impact News +++ QVC Is in Talks With Creditors to Restructure Debt in Bankruptcy (Bloomberg) +++ QVC Aktie -11,14%

Gewinn & Umsatz News zur INCYTE Aktie

>INCYTE Aktienkurs

85.46 EUR -6.7% (TradegateBSX)

Ask: 85.42 EUR / 240 Stück

Bid: 85.12 EUR / 240 Stück

Tagesumsatz: 1726 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

INCYTE Aktie über LYNX handeln

Intraday

1 Jahr

>INCYTE Performance

1 Woche: +5,1%

1 Monat: -0,9%

3 Monate: +0,1%

6 Monate: +36,3%

1 Jahr: +26,5%

laufendes Jahr: +8,4%

>INCYTE Aktie

Name:

INCYTE DL-,001

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US45337C1027 / 896133

Symbol/ Ticker:

ICY (Frankfurt) / INCY (NASDAQ)

Kürzel:

FRA:ICY, ETR:ICY, ICY:GR, NASDAQ:INCY

Index:

S&P500

Webseite:

https://incyte.com/

Profil:

Incyte Corporation is a biopharmaceutical company ..
>Volltext..

Marktkapitalisierung:

17075.59 Mio. EUR

Unternehmenswert:

14621.56 Mio. EUR

Umsatz:

4073.86 Mio. EUR

EBITDA:

1141.29 Mio. EUR

Nettogewinn:

1006.03 Mio. EUR

Gewinn je Aktie:

5.17 EUR

Schulden:

34.93 Mio. EUR

Liquide Mittel:

2077.94 Mio. EUR

Operativer Cashflow:

1059.21 Mio. EUR

Bargeldquote:

2.19

Umsatzwachstum:

12.05%

Gewinnwachstum:

3372.01%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

INCYTE

Letzte Datenerhebung:

10.02.26

>INCYTE Kennzahlen

Aktien/ Unternehmen:

Aktien: 196.32 Mio. St.

Frei handelbar: 98.86%

Leerverk. Aktien: 5.5%

Rückkaufquote: -0.37%

Mitarbeiter: 2617

Umsatz/Mitarb.: 1.37 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 5.27%

Bewertung:

KGV: 16.8

KGV lG: 14.85

KUV: 4.31

KBV: 4.22

PEG-Ratio: -

EV/EBITDA: 12.81

Rentabilität:

Bruttomarge: 91.55%

Gewinnmarge: 24.69%

Operative Marge: 26.1%

Managementeffizenz:

Gesamtkaprendite: 20.96%

Eigenkaprendite: 30.39%

>INCYTE Peer Group

Gesundheit, Onkologie/ Krebs- Behandlung

>INCYTE Chart & Kurs - NASDAQ

>INCYTE Gewinn & Umsatz News

10.02.26 - 14:06	Incyte Corporation Q4 Profit Increases, Beats Estimates (AFX)
	WASHINGTON (dpa-AFX) - Incyte Corporation (INCY) announced earnings for its fourth quarter that Increased from last year and beat the Street estimates.The company's bottom line totaled $299.3 mill......

28.10.25 - 13:18	Incyte Corporation Q3 Profit Increases, Beats Estimates (AFX)
	WASHINGTON (dpa-AFX) - Incyte Corporation (INCY) revealed a profit for its third quarter that Increased from the same period last year and beat the Street estimates.The company's earnings totaled ......

17.09.25 - 08:48	Incyte Reports Encouraging 24-Week Results From Phase 3 STOP-HS Program Of Povorcitinib (AFX)
	WASHINGTON (dpa-AFX) - Incyte Corporation (INCY) on Wednesday announced encouraging 24-week data from the pivotal Phase 3 STOP-HS program evaluating povorcitinib in adults with hidradenitis suppur......

29.07.25 - 15:01	Incyte Q2 Results Top Estimates (AFX)
	WASHINGTON (dpa-AFX) - Incyte Corp. (INCY) on Tuesday reported net income of $405.0 million or $2.04 per share for the second quarter, compared to a net loss of $444.60 million or $2.04 per share ......

10.07.25 - 15:06	Incyte′s Q2 2025 Earnings: What to Expect (Barchart)
	Incyte is gearing up to report its fiscal second-quarter earnings later this month, with analysts forecasting a sharp surge in profitability, projecting triple-digit year-over-year profit growth....

29.04.25 - 14:18	Incyte Q1 Results Top Estimates (AFX)
	WASHINGTON (dpa-AFX) - Incyte Corp. (INCY) on Tuesday reported net income of $158.20 million or $0.80 per share for the first quarter, lower than $169.55 million or $0.75 per share in the prior-ye......

16.04.25 - 13:30	Incyte Earnings Preview: What to Expect (Barchart)
	Incyte is all set to release its fiscal first-quarter earnings later this month, and analysts project a high double-digit profit growth....

09.03.25 - 04:01	Lilly Reveals Positive Phase 3 Results For Adolescent Alopecia Areata Treatment With Baricitinib (AFX)
	INDIANAPOLIS (dpa-AFX) - Eli Lilly and Co. (LLY) and Incyte's (INCY) late-breaking results from Phase 3 BRAVE-AA-PEDS study found adolescent patients (ages 12 to under 18) with severe alopecia are......

10.02.25 - 14:18	Incyte Q4 Adj. EPS Misses Estimates, Revenues Beat; Sees Revenue Growth In FY25 (AFX)
	WASHINGTON (dpa-AFX) - Pharma company Incyte Corp. (INCY) reported Monday slightly higher earnings in its fourth quarter with strong growth in revenues. Adjusted earnings missed the Wall Street vi......

17.01.25 - 09:30	What You Need to Know Ahead of Incytes Earnings Release (Barchart)
	Biopharma major Incyte is expected to announce its fourth-quarter results later this month and analysts expect a significant double-digit growth in earnings....

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Das Gegenwärtige ist begrenzt. Das Mögliche ist unermeßlich. - Abraham Lincoln

Partner: >TradegateBSX Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram